Navigation Links
Tongjitang Chinese Medicines Company Announces Resignation of CFO, Effective December 2, 2010
Date:9/8/2010

Tongjitang Chinese Medicines Company Announces Resignation of CFO, Effective December 2, 2010 -- SHENZHEN, China, Sept. 8 /PRNewswire-Asia-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Supplementary Medicine, Personnel Announcements Click to view news release full screen  

Tongjitang Chinese Medicines Company Announces Resignation of CFO, Effective December 2, 2010

 

SHENZHEN, China, Sept. 8 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced that on September 3, 2010, Mr. Charles Wang submitted his resignation as Chief Financial Officer for personal reasons and not as a result of any disagreement with the Company regarding financial or accounting practices. The resignation will be effective on December 2, 2010.

Mr. Charles Wang is expected to stay with the company until December. The Company has commenced an executive search in order to find a replacement.

Xiaochun Wang, Tongjitang's Chief Executive Officer and Chairman of the Board of Directors, stated, "On behalf of the Board, management, and employees of our company, I'd like to thank Mr. Charles Wang for his dedication and contribution to Tongjitang over the past two years and wish him all the best on his future endeavors."

About Tongjitang Chinese Medicines Company

Tongjitang Chinese Medicines Company, through its operating subsidiaries Tongjitang Pharmaceutical, Tongjitang Distribution, Tongjitang Chain Stores, Guizhou Long-Life Pharmaceutical Company Limited, Qinghai Pulante, Anhui Jingfang and Gui Liqour Ltd., is a vertically integrated specialty pharmaceutical company focused on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China. Tongjitang's principal executive offices are located in Shenzhen, China.

Tongjitang's flagship product, Xianling Gubao, is the leading traditional Chinese medicine for the treatment of osteoporosis in China as measured by sales in Renminbi. In addition to Xianling Gubao, the Company manufactures and markets 35 other modernized traditional Chinese medicine products and 36 western medicines. Please visit http://www.tongjitang.com for more information.

For more information, please contact: ICR, Inc. Ashley M. Ammon or Christine Duan Phone: +1-203-682-8200 (Investor Relations)
'/>"/>

SOURCE Tongjitang Chinese Medicines Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tongjitang Chinese Medicines Company Reports Second Quarter 2010 Financial Results
2. Tongjitang Files 2009 Annual Report on Form 20-F
3. Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results
4. Tongjitang Chinese Medicines Acquires Guiyang Liquor Factory
5. China Medical Technologies Announces the Use of its HER-2 FISH Probe in a Cancer Targeted Therapy Research Project Sponsored by the Chinese Ministry of Health
6. China BCT Signs Exclusive Distribution Contract With Liujiang County Chinese Medicine Hospital
7. Biosites Triage Products Seized by Beijing Customs; Chinese Market Facing Shortage
8. China Sky One Medical Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology
9. Chinese Distribution Contract Extended for an Additional 4 Years
10. Chinese State Food and Drug Administration Approves Company Facility for Producing Solid Dosage Perindopril
11. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Ofloxacin and Fleroxacin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... 19, 2017  nThrive™, an independent Patient-to-Payment? solutions ... thought leadership at the 2017 HIMSS Conference. The ... award from KLAS. nThrive will host ... how market trends shape the holistic, integrated revenue ... comprehensive Patient Access solution. The panel will reveal ...
(Date:2/18/2017)... HILL, N.C. , Feb. 17, 2017  Pharmaceutical companies ... insights about products either in development or already on the ... have forced the pharma industry to alter how it manages ... boards, consulting leader Best Practices, LLC conducted a new study ... ...
(Date:2/17/2017)... Feb. 17, 2017 Theravance Biopharma, Inc. ... the "Company") today announced the presentation of positive ... orally administered pan-Janus kinase (JAK) inhibitor designed to ... Congress of the European Crohn,s and Colitis Organization ... further data from its completed Phase 1 study ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... ... educational assistance management solution to the exhibit floor for the 2017 HIMSS ... , From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental ... for each and every seminar, session and class she offers. At the ... tools which help energize creativity, focus mental functions, enhance athletic focus and skill ...
(Date:2/17/2017)... ... February 17, 2017 , ... Qualis Health, one of ... the 8th Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare management ... recognized across multiple award categories, highlighting four of the organization’s current programs:, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program ... , Trinity Health and the U.S. Soccer Foundation announced today that they have ... communities. Soccer for Success, the Foundation’s soccer mentoring program, teaches kids the fundamentals ...
(Date:2/17/2017)... ... 2017 , ... Pharmica Consulting attended CHI's 8th Annual SCOPE ... trial planning and management. Pharmica discussed the importance of effective project management, data ... by Pharmica’s booth were able to demo its cloud-based Resource Management Tool, ...
Breaking Medicine News(10 mins):